p90RSK: a new target of Enzastaurin in follicular lymphoma cells

Conclusions and ImplicationsThus, the targeting of p90RSK by Enzastaurin represents a new therapeutic option for follicular lymphoma treatment.

Source: British Journal of Pharmacology - August 28, 2013 Category: Drugs & Pharmacology Authors: S Kheirallah, S Fruchon, L Ysebaert, A Blanc, F Capilla, A Marrot, T AlSaati, F X Frenois, K A Benhadji, JJ Fournié, G Laurent, C Bezombes Tags: Research Paper Source Type: research